AF
Ally Financial Portfolio holdings
AUM
$885M
This Quarter Return
+2.41%
1 Year Return
+3.05%
3 Year Return
+25.92%
5 Year Return
+35.24%
10 Year Return
+35.99%
AUM
$444M
AUM Growth
+$444M
(-25%)
Cap. Flow
-$170M
Cap. Flow
% of AUM
-38.33%
Top 10 Holdings %
Top 10 Hldgs %
32.41%
Holding
119
New
16
Increased
35
Reduced
12
Closed
17
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
$12.4M |
| 2 |
Microsoft
MSFT
|
$9.22M |
| 3 |
Wells Fargo
WFC
|
$4.62M |
| 4 |
Verizon
VZ
|
$4.29M |
| 5 |
GE Aerospace
GE
|
$4.02M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$69.3M |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
$52.1M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$25M |
| 4 |
Apple
AAPL
|
$17.2M |
| 5 |
Walt Disney
DIS
|
$11.5M |
Sector Composition
| 1 | Healthcare | 15.02% |
| 2 | Financials | 13.01% |
| 3 | Energy | 9.85% |
| 4 | Communication Services | 9.45% |
| 5 | Consumer Staples | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Citigroup
C
$175B
| $5.09M | 1.15% |
85,000
+45,000
| +113% | +$2.69M |
|
27
Qualcomm
QCOM
$170B
| $5.05M | 1.14% |
88,000
+18,000
| +26% | +$1.03M |
|
|
28
Verizon
VZ
$184B
| $4.88M | 1.1% |
100,000
+88,000
| +733% | +$4.29M |
|
29
Schlumberger
SLB
$52.2B
| $4.69M | 1.06% |
60,000
| – | – |
|
|
30
Wells Fargo
WFC
$258B
| $4.62M | 1.04% |
+83,000
| New | +$4.62M |
|
31
Occidental Petroleum
OXY
$45.6B
| $4.44M | 1% |
70,000
| – | – |
|
32
Gilead Sciences
GILD
$140B
| $4.42M | 1% |
65,000
| – | – |
|
33
AbbVie
ABBV
$374B
| $4.24M | 0.95% |
65,000
| – | – |
|
34
Biogen
BIIB
$20.5B
| $4.1M | 0.92% |
15,000
| – | – |
|
35
PepsiCo
PEP
$203B
| $3.92M | 0.88% |
35,000
| – | – |
|
36
Thermo Fisher Scientific
TMO
$183B
| $3.84M | 0.87% |
25,000
+7,000
| +39% | +$1.08M |
|
|
AGN
37
DELISTED
Allergan plc
AGN
| $3.82M | 0.86% |
16,000
+1,000
| +7% | +$239K |
|
38
United Parcel Service
UPS
$72.3B
| $3.76M | 0.85% |
+35,000
| New | +$3.76M |
|
|
WBA
39
DELISTED
Walgreens Boots Alliance
WBA
| $3.74M | 0.84% |
45,000
| – | – |
|
40
Intel
INTC
$105B
| $3.61M | 0.81% |
100,000
+25,000
| +33% | +$902K |
|
41
JPMorgan Chase
JPM
$824B
| $3.51M | 0.79% |
+40,000
| New | +$3.51M |
|
42
McKesson
MCK
$85.9B
| $3.41M | 0.77% |
23,000
+3,000
| +15% | +$445K |
|
43
Viatris
VTRS
$12.3B
| $3.31M | 0.75% |
85,000
| – | – |
|
|
ESRX
44
DELISTED
Express Scripts Holding Company
ESRX
| $3.3M | 0.74% |
50,000
| – | – |
|
45
Merck
MRK
$210B
| $3.18M | 0.72% |
52,400
+31,440
| +150% | +$1.91M |
|
46
Invesco
IVZ
$9.68B
| $3.06M | 0.69% |
100,000
+20,000
| +25% | +$613K |
|
47
Target
TGT
$42B
| $3.04M | 0.68% |
+55,000
| New | +$3.04M |
|
48
Bristol-Myers Squibb
BMY
$96.7B
| $2.99M | 0.67% |
55,000
+20,000
| +57% | +$1.09M |
|
49
Ford
F
$46.2B
| $2.97M | 0.67% |
255,000
+100,000
| +65% | +$1.16M |
|
|
PX
50
DELISTED
Praxair Inc
PX
| $2.97M | 0.67% |
25,000
| – | – |
|